- Filed
- May 17, 2021 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2021 · May 7, 2021 | 515.21M sh |
| Cash And Equivalents | Q1 2021 · Mar 31, 2021 | $758K |
| Cash And Equivalents | Q1 2021 · Dec 31, 2020 | $404K |
| Cash And Equivalents restated | Q1 2021 · Mar 31, 2020 | $146K |
| Cash And Equivalents restated | Q1 2021 · Dec 31, 2019 | $23K |
| Current Liabilities | Q1 2021 · Mar 31, 2021 | $30.1M |
| Current Liabilities | Q1 2021 · Dec 31, 2020 | $12.91M |
| Total Liabilities | Q1 2021 · Mar 31, 2021 | $30.1M |
| Total Liabilities | Q1 2021 · Dec 31, 2020 | $12.91M |
| Current Assets | Q1 2021 · Mar 31, 2021 | $758K |
| Current Assets | Q1 2021 · Dec 31, 2020 | $404K |
| Total Assets | Q1 2021 · Mar 31, 2021 | $758K |
| Total Assets | Q1 2021 · Dec 31, 2020 | $404K |
| Operating Cash Flow | Q1 2021 · Mar 31, 2020 | −$127K |
| Stockholders Equity restated | Q1 2021 · Mar 31, 2020 | −$8.72M |
| Stockholders Equity | Q1 2021 · Dec 31, 2019 | −$8.72M |
| Sga Expense | Q1 2021 · Mar 31, 2020 | $114K |
| Rd Expense | Q1 2021 · Mar 31, 2020 | $11K |
| Net Income | Q1 2021 · Mar 31, 2020 | −$726K |
| Operating Income | Q1 2021 · Mar 31, 2020 | −$125K |